A new model of active specific immunothe
โ
Moriguchi, Yoshio; Kan, Norimichi; Okino, Takashi; Harada, Takehisa; Yamasaki, S
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 716 KB
The possibility of active specific immunotherapy using interleukin-1 (IL-1) plus sonicated tumor supernatant (SS) was examined in a murine tumor model. The growth of intraperitoneally or subcutaneously inoculated plasmacytoma MOPC IME, which is syngeneic to BALB/c mice, was significantly suppressed